Ahmad S H, Hasan K Z
J Pak Med Assoc. 1977 Apr;27(4):313-6.
In acutely disturbed newly admitted patients at Neuropsychiatric Unit, Karachi, the efficacy of thiothixene is not significantly different as compared to trifluoperazine. In trifluoperazine group also all the target symptoms improved while 'depressive mood' and 'suspiciousness' did not change significantly. In thiothixene group significant improvement was noticed on all the target symptoms except 'tension' and 'depressive mood'. The ethnic or genetic make up of the patient population was concluded to be the reason for non-effectiveness of thisthixene on effective psychopathology in acute schizophrenia. The extra-pyramidal side effects were clinically more pronounced in thiothixene group.
在卡拉奇神经精神科新收治的急性精神障碍患者中,硫利达嗪的疗效与三氟拉嗪相比无显著差异。在三氟拉嗪组中,所有目标症状均有改善,但“抑郁情绪”和“猜疑”无显著变化。在硫利达嗪组中,除“紧张”和“抑郁情绪”外,所有目标症状均有显著改善。得出结论,患者群体的种族或基因构成是硫利达嗪对急性精神分裂症有效精神病理学无效的原因。硫利达嗪组的锥体外系副作用在临床上更为明显。